EP0176567A4 - LENS FOR IMPLANTATION IN THE REAR EYE. - Google Patents
LENS FOR IMPLANTATION IN THE REAR EYE.Info
- Publication number
- EP0176567A4 EP0176567A4 EP19850901883 EP85901883A EP0176567A4 EP 0176567 A4 EP0176567 A4 EP 0176567A4 EP 19850901883 EP19850901883 EP 19850901883 EP 85901883 A EP85901883 A EP 85901883A EP 0176567 A4 EP0176567 A4 EP 0176567A4
- Authority
- EP
- European Patent Office
- Prior art keywords
- lens body
- lens
- intraocular lens
- flexible ring
- recited
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000002775 capsule Substances 0.000 claims abstract description 57
- 206010016654 Fibrosis Diseases 0.000 claims abstract description 28
- 230000004761 fibrosis Effects 0.000 claims abstract description 25
- 208000002177 Cataract Diseases 0.000 claims abstract description 19
- 230000003287 optical effect Effects 0.000 claims abstract description 18
- 230000004888 barrier function Effects 0.000 claims abstract description 15
- 238000000605 extraction Methods 0.000 claims abstract description 13
- 230000005012 migration Effects 0.000 claims abstract description 9
- 238000013508 migration Methods 0.000 claims abstract description 9
- 239000000463 material Substances 0.000 claims description 7
- 238000000034 method Methods 0.000 claims description 6
- 239000004743 Polypropylene Substances 0.000 claims description 4
- -1 polypropylene Polymers 0.000 claims description 4
- 229920001155 polypropylene Polymers 0.000 claims description 4
- 230000001737 promoting effect Effects 0.000 claims description 3
- 230000001788 irregular Effects 0.000 claims description 2
- ZZUFCTLCJUWOSV-UHFFFAOYSA-N furosemide Chemical compound C1=C(Cl)C(S(=O)(=O)N)=CC(C(O)=O)=C1NCC1=CC=CO1 ZZUFCTLCJUWOSV-UHFFFAOYSA-N 0.000 claims 1
- 210000002919 epithelial cell Anatomy 0.000 abstract description 2
- 210000004027 cell Anatomy 0.000 description 7
- 239000007943 implant Substances 0.000 description 4
- 230000012292 cell migration Effects 0.000 description 3
- 208000008516 Capsule Opacification Diseases 0.000 description 2
- 208000002367 Retinal Perforations Diseases 0.000 description 2
- 238000013461 design Methods 0.000 description 2
- 239000000835 fiber Substances 0.000 description 2
- 230000004402 high myopia Effects 0.000 description 2
- 230000033001 locomotion Effects 0.000 description 2
- 239000011049 pearl Substances 0.000 description 2
- 229920003229 poly(methyl methacrylate) Polymers 0.000 description 2
- 239000004926 polymethyl methacrylate Substances 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 210000001747 pupil Anatomy 0.000 description 2
- 238000001356 surgical procedure Methods 0.000 description 2
- 208000006069 Corneal Opacity Diseases 0.000 description 1
- 208000010412 Glaucoma Diseases 0.000 description 1
- 206010025421 Macule Diseases 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 206010036346 Posterior capsule opacification Diseases 0.000 description 1
- 208000035965 Postoperative Complications Diseases 0.000 description 1
- 208000037111 Retinal Hemorrhage Diseases 0.000 description 1
- 206010038848 Retinal detachment Diseases 0.000 description 1
- 206010063942 Vitreous loss Diseases 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 210000002159 anterior chamber Anatomy 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 231100000269 corneal opacity Toxicity 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 210000004209 hair Anatomy 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 230000004379 myopia Effects 0.000 description 1
- 208000001491 myopia Diseases 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- NQLVQOSNDJXLKG-UHFFFAOYSA-N prosulfocarb Chemical compound CCCN(CCC)C(=O)SCC1=CC=CC=C1 NQLVQOSNDJXLKG-UHFFFAOYSA-N 0.000 description 1
- 231100000241 scar Toxicity 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 230000000087 stabilizing effect Effects 0.000 description 1
- 229940035718 sular Drugs 0.000 description 1
- 230000037303 wrinkles Effects 0.000 description 1
Classifications
-
- H—ELECTRICITY
- H04—ELECTRIC COMMUNICATION TECHNIQUE
- H04N—PICTORIAL COMMUNICATION, e.g. TELEVISION
- H04N7/00—Television systems
- H04N7/12—Systems in which the television signal is transmitted via one channel or a plurality of parallel channels, the bandwidth of each channel being less than the bandwidth of the television signal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/14—Eye parts, e.g. lenses or corneal implants; Artificial eyes
- A61F2/16—Intraocular lenses
-
- H—ELECTRICITY
- H03—ELECTRONIC CIRCUITRY
- H03F—AMPLIFIERS
- H03F1/00—Details of amplifiers with only discharge tubes, only semiconductor devices or only unspecified devices as amplifying elements
- H03F1/08—Modifications of amplifiers to reduce detrimental influences of internal impedances of amplifying elements
- H03F1/18—Modifications of amplifiers to reduce detrimental influences of internal impedances of amplifying elements by use of distributed coupling, i.e. distributed amplifiers
- H03F1/20—Modifications of amplifiers to reduce detrimental influences of internal impedances of amplifying elements by use of distributed coupling, i.e. distributed amplifiers in discharge-tube amplifiers
Definitions
- the present invention pertains to intraocular lenses and more particularly to intraocular lenses for implanting in the posterior chamber of the eye after extracapsular cataract extraction.
- intraocular lenses after cataract surgery has become an accepted practice, and there are many intraocular lens designs available for positioning in the anterior chamber or posterior chamber of the eye or for support on the iris.
- cataract surgery it is preferable to extract the lens while leaving the posterior portion of the lens capsule intact to pro- vide a barrier to prevent movement or loss of the vitreous which fills the eye behind the lens.
- intracap- sular cataract extraction the vitreous can move through the pupil causing vitreous loss and increasing the chances of complications, such as glaucoma, corneal opacity, dis ⁇ placement of the intraocular lens, retinal hemorrhage, holes, breaks and detachment., and cystoid macula edema.
- the posterior capsule becomes opacified due to migration of crystalline, epithalial cells into the optical zone behind the lens which, clustered, form Elschnig*s pearls.
- This opacifi- cation of the posterior capsule referred to as second ⁇ ary cataract, occurs in a large percentage of extra ⁇ capsular cataract extractions and is a primary cause of post operative complications.
- the procedures to remove the secondary cataract include descission using a needle or scissors to punch or cut a hole in the posterior cap ⁇ sule and the use of a laser focused through the pupil to open the posterior capsule. While the posterior cap- sulotomy removes the opacification to improve sight, it carries with it the adverse effects discussed above with respect to intracapsular cataract extraction relating to the removal of the barrier to vitreous movement.
- U.S. Patent Re. 31,626 to Hoffer discusses an intraocular lens having a lens body with a unitary, rearwardly projecting, substantially annular ridge or lip to seat against the posterior capsule. It is indicated that the lip may serve as a barrier to mi ⁇ gration of cells and fiber development; however, since the implanted intraocular lens has less volume than the removed natural lens, the posterior capsule is " normally wavy and wrinkled preventing the lip from complete engage ⁇ ment with the posterior capsule. Additionally, with age the capsule becomes more wrinkled and the zonules lose elasticity. Since the lip is rigid, it will not become attached to the posterior capsule in the manner that the pliant hairs are fixed by fibrosis in the capsule fornix region.
- a primary object of the present invention to overcome the above-mentioned defi ⁇ ciencies of the prior art by producing a ring of fibrosis around the optical zone of a posterior capsule after extracapsular cataract extraction to prevent migration of crystalline cells into the optical ..zone and thereby prevent clouding or opacification.
- Another object of the present invention is configure an intraocular lens to have a flexible filament ring extending from the lens body to engage the posterior capsule after implant in the posterior chamber to promote fibrosis producing a barrier to crystalline cell migration.
- the present invention has another object in the design of an intraocular lens preventing secondary cata ⁇ ract and stabilizing the lens body centrally of the iris by adhesion of a ring to the posterior capsule.
- An additional object of the present invention is to obviate the need to open the posterior capsule after extracapsular cataract extraction and implant of an in ⁇ traocular lens by preventing migration of crystalline cells into the optical zone and thereby preventing opacification or secondary cataract.
- the intraocular lens of the present invention facilitates implant by the surgeon, is flexible to compensate for wrinkles and waves in the posterior capsule, adheres to the posterior capsule to positively centralize the lens body behind the iris, creates through the natural process of fibrosis a barrier. to crystalline cell migration and is relatively inexpen ⁇ sive to manufacture.
- the present invention is generally characterized in an intraocular lens for implanting in the posterior chamber of the eye including a lens body, fixation means extending from the lens body to engage portions of the eye in the posterior chamber and bias the lens body to ⁇ ward the posterior capsule of the eye, and a flexible ring extending rearwardly from the lens body to engage the posterior capsule completely enclosing an optical zone of the posterior capsule behind the lens body whereby the flexible ring creates fibrosis to produce a barrier to migration of crystalline cells into the optical zone.
- the present invention is further generally characterized in a method of preventing opacification of the posterior capsule of the eye after extracapsular cataract extraction comprising the steps of positioning an intraocular lens in the posterior chamber of the eye, the intraocular lens having a lens body and a flexible ring extending therefrom, and biasing the flexible ring against the posterior capsule to create fibrosis and form an enclosing fibrosis-created barrier around an optical zone behind the lens body to prevent migration of crystalline cells into the optical zone.
- Fig. 1 is a top plan view of an intraocular lens in accordance with the present invention.
- Fig. 2 is a side view of the intraocular lens of Fig. 1.
- Fig. 3 is a top, plan view of another intra ⁇ ocular lens in accordance with the present invention.
- Fig. 4 is a side view of the intraocular lens of Fig. 3.
- Fig. 5 is a partial section of an eye with the intraocular lens of Fig. 3 implanted after extracapsular cataract extraction.
- FIGs. 1 and 2 An intraocular lens in accordance with the pre ⁇ sent invention is illustrated in Figs. 1 and 2 and includes a lens body 12 constructed of a clear plastic, such as polymethylmethacrylate, lathe cut or molded to have a desired configuration.
- lens body 12 has con ⁇ vex front and rear surfaces 14 and 16, respectively; and, fixation elements in the form of flexible loops 18 and 20 are secured in bores in opposite sides of the lens body and extend away from the periphery of the lens body and upward away from the rear surface 16.
- the loops are made of a very flexible material such as polypropylene and have free ends to engage the sulcus or the posterior capsule when the intraocular lens is implanted in the posterior chamber with the loops being compressed to permit the intraocular lens to adapt to eyes of varying dimenstions.
- a positioning hole 22 is disposed in the front surface 14 of the lens body to facilitate maneuver ⁇ ing of the intraocular lens by the surgeon.
- the intraocular lens is conventional; and, it will be appreciated that the lens body and the loops of intraocular lenses in accordance with.the present invention can have any desired configurations.
- Attached to the lens body 12 in accordance with the present invention is a flexible ring 24 formed of an annular filament 26 spaced from the rear surface 16 of the lens body and attached to the periphery of the lens body by diametrically opposed struts 28 and 30.
- the struts are staked in bores in the periphery of the lens body and are angled away from the lens body such that the annular filament 26 is spaced laterally from the peripheral edge of the lens body as well as being spaced rearwardly from the rear surface of the lens body.
- the ring 24 is made of very flexible filaments of ma ⁇ terial that promotes fibrosis when contacting the pos ⁇ terior capsule, such as polyprooylene. As will be explained in more detail hereinafter, the ring must be sufficiently flexible to engage the posterior capsule at all points even when the capsule is wavy and wrinkled such that a complete ring formed by fibrosis is obtained.
- ring as used herein is not meant to be limi ⁇ ted to an annular shape but rather is meant to include any configuration producing an enclosing border or frame around the optical zone of the lens body, for example, elliptical or regularly or irregularly polygonal.
- the power of the lens body can range from -6 to +30 diopters; and in one exemplary embodiment, the diameter of the lens body is 7 mm, the filaments of the flexible ring and the loops are 0.15 * mm in diameter, the diameter of the ring formed by the annular filament is 8 mm (i.e., greater than the diameter of the lens body), the ring formed by the annular filament is spaced 0.5 mm from the rear surface of the lens body, the length from end to end of the loops is 14 mm, and the loops extend away from the lens body at an angle of 10 °.
- Another embodiment of an intraocular lens 110 ciccording to the present invention is illustrated in Figs.
- lens body 112 having a convex front surface 114 and a planar rear surface 116 with oppositely extending fixation elements or loops 118 and L20 having a greater radius of curvature than the loops of intraocular lens 10.
- the lens body 112 and the loops 118 and 120 are formed integrally of polymethylmetha- cryla e as one piece, and a pair of diametrically opposed positioning holes 122 are disposed in the front surface of the lens body.
- the differences in construction and configuration of the lens bodies and loops of the embodi ⁇ ments of Figs 1 and 3 are shown to illustrate that the flexible ring according to the present invention can be used with various types of intraocular lenses.
- the flexible ring 124 of the intraocular lens 110 is formed of two 180° arcuate filament segments 126a and 126b each having upwardly and inwardly extending legs or struts 128 and 130 at opposite ends thereof to be received in bores in the rear surface 116 of the lens body such that the ring formed by segments 126a and 126b is spaced behind the rear surface 116 and laterally from the periphery of the lens body producing an enclosing border or frame around the optical zone of the lens body.
- the flexible ring filaments are made of very flexible material enhancing fibrosis, such as polypropylene, to provide 360° contact with the posterior capsule, as men ⁇ tioned above; and, the legs 128 and 130 are positioned adjacent each other, preferably abutting, such that the fibrosis barrier produced by the ring is continuous with no gaps, the fibrosis filling any interstice between the segments.
- the intraocular lens 110 can have a wide range of powers as mentioned above; and, in an exemplary em ⁇ bodiment, the diameter of the lens body is 7 mm, the fila- ments of the flexible ring are 0.15 mm in diameter, the diameter of the flexible ring formed by the segments 126a and 126b is spaced 0.1 mm from the rear surface of the lens body, the length from end to end of the loops is 14 mm and the loops extend away from the lens body at an angle of 9°.
- Intraocular lens 110 is illustrated in Fig. 5 implanted in the posterior chamber of the eye after ex ⁇ tracapsular cataract extraction, the ends of loops 118 and 120 being seated in the sulcus 132.
- the angle of the loops 118 and 120 forces the flexible ring 124 against the posterior capsule 134 such that the filaments 126a and 126b engage the capsule at all points, the flexible nabure of the filaments enabling contact of the ring with the capsule at all points even though the capsule is wavy and wrinkled.
- the loops are shown posi ⁇ tioned in the sulcus, the loops can also be positioned in the cjpsule if desired, it being of primary interest only that the flexible ring is biased against the posterior capsule.
- fibrosis will develop around the filaments securing the ring to the capsule and forming a continuous barrier around the optical zone of the lens body. Fibrosis is the reaction by the body to a foreign object and involves the formation of col ⁇ lagen fibers or scar tissue which grow around the foreign object.
- the fibrosis will attach to the ring, and it is the fibrosis that forms, with the ring, the continuous barrier on the capsule. It is important to note that fibrosis will not attach to rigid solid objects, such as the ridge in the Hoffer patent Re. 31626, to form a bar ⁇ rier.
- the fibrosis- formed ring prevents migration of crystalline, epithelial cells along the capsule from the perimeter into the opti ⁇ cal zone circumscribed by the ring thereby preventing clustering of cells to form Elschnig's pearls and main ⁇ taining the capsule transparent.
- intra ⁇ ocular lenses according to the present invention are parti- cularly useful for patients suffering from high myopia in that the 7 mm lens body facilitates centering and the extremely flexible loops are better tolerated by the sensitive tissue of the high myope.
- High myopia is one of the principal causes of cataracts; and, thus, it is important that lenses be designed to be implanted in -patients with hgih myopia.
- the lens body and the fixation means of the intraocular lens can have any desirable con ⁇ figurations in accordance with the present invention, it being of primary importance only that fixation of the intraocular lens in the posterior chamber places the flexible ring in contact with the posterior capsule to create a complete ring of fibrosis.
- the filamentous material of the flexible ring is of a nature to promote fibrosis and cause the ring to adhere to the capsule producing a bar ⁇ rier to cell migration and also causing the lens body to be stabilized in a central position behind the iris.
- the adhesion of the ring to the capsule can be enhanced by providing the filaments with an irregular surface.
- Materials known to be effective in promoting fibrosis to adhere the ring to the capsule include filaments of polypropylene or polymethylmethacrylate; however, the filaments could also be treated or coated with a material to enhance the process of fibrosis.
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Ophthalmology & Optometry (AREA)
- Vascular Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Transplantation (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Multimedia (AREA)
- Signal Processing (AREA)
- Power Engineering (AREA)
- Prostheses (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT03413/84A IT1179308B (it) | 1984-04-05 | 1984-04-05 | Lente intraoculare impiantabile in camera posteriore |
| IT341384 | 1984-04-05 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| EP0176567A1 EP0176567A1 (en) | 1986-04-09 |
| EP0176567A4 true EP0176567A4 (en) | 1987-07-06 |
Family
ID=11106790
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EP19850901883 Pending EP0176567A4 (en) | 1984-04-05 | 1985-04-04 | LENS FOR IMPLANTATION IN THE REAR EYE. |
Country Status (3)
| Country | Link |
|---|---|
| EP (1) | EP0176567A4 (it) |
| IT (1) | IT1179308B (it) |
| WO (1) | WO1985004566A1 (it) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE8505518D0 (sv) * | 1985-11-22 | 1985-11-22 | Swedish Graft Tech Ab | Implantationslins, forfarande for framsstellning derav och anordning for att utfora forfarandet |
| US4725276A (en) * | 1986-09-04 | 1988-02-16 | Precision-Cosmet Co., Inc. | Intraocular lens with continuous posterior ring-like member |
| DE3901435A1 (de) * | 1989-01-19 | 1990-08-02 | Kurt A Morcher Fa | Intraoculare linse |
| ATE139683T1 (de) * | 1990-12-03 | 1996-07-15 | Adatomed Pharma Chiron | Intraokulare künstliche augenlinse |
| FR2728458A1 (fr) * | 1994-12-26 | 1996-06-28 | Guilbert Guillaume Benjamin Ge | Lentille intra-oculaire correctrice et anti-migrations cellulaires |
| US20030078657A1 (en) * | 2001-01-25 | 2003-04-24 | Gholam-Reza Zadno-Azizi | Materials for use in accommodating intraocular lens system |
| US7780729B2 (en) | 2004-04-16 | 2010-08-24 | Visiogen, Inc. | Intraocular lens |
| WO2025251126A1 (pt) * | 2024-06-03 | 2025-12-11 | Duarte Camargos Marcelo | "dispositivo óptico com proporção áurea" |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4073015A (en) * | 1976-05-07 | 1978-02-14 | Peyman Gholam A | Artificial intraocular lens attachment |
| WO1984000883A1 (en) * | 1982-09-02 | 1984-03-15 | Lawrence D Castleman | Intraocular posterior chamber lens |
| US4562600A (en) * | 1983-10-18 | 1986-01-07 | Stephen P. Ginsberg | Intraocular lens |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4244060A (en) * | 1978-12-01 | 1981-01-13 | Hoffer Kenneth J | Intraocular lens |
| US4285072A (en) * | 1979-05-14 | 1981-08-25 | Harry H. Leveen | Anterior-posterior intraocular lens |
| US4304012A (en) * | 1979-10-05 | 1981-12-08 | Iolab Corporation | Intraocular lens assembly with improved mounting to the iris |
| US4412359A (en) * | 1982-04-26 | 1983-11-01 | Myers William D | Posterior chamber lens implant |
-
1984
- 1984-04-05 IT IT03413/84A patent/IT1179308B/it active
-
1985
- 1985-04-04 WO PCT/US1985/000573 patent/WO1985004566A1/en not_active Ceased
- 1985-04-04 EP EP19850901883 patent/EP0176567A4/en active Pending
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4073015A (en) * | 1976-05-07 | 1978-02-14 | Peyman Gholam A | Artificial intraocular lens attachment |
| WO1984000883A1 (en) * | 1982-09-02 | 1984-03-15 | Lawrence D Castleman | Intraocular posterior chamber lens |
| US4562600A (en) * | 1983-10-18 | 1986-01-07 | Stephen P. Ginsberg | Intraocular lens |
Non-Patent Citations (1)
| Title |
|---|
| See also references of WO8504566A1 * |
Also Published As
| Publication number | Publication date |
|---|---|
| WO1985004566A1 (en) | 1985-10-24 |
| IT1179308B (it) | 1987-09-16 |
| EP0176567A1 (en) | 1986-04-09 |
| IT8403413A0 (it) | 1984-04-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US4738680A (en) | Laser edge lens | |
| US4842599A (en) | Prosthetic cornea and method of implantation therefor | |
| EP0246216B1 (en) | Intraocular lens with tapered haptics | |
| US4244060A (en) | Intraocular lens | |
| US4880427A (en) | Flexible posterior chamber lens | |
| US4477931A (en) | Intraocular lens with flexible C-shaped supports | |
| US6224628B1 (en) | Haptics for an intraocular lens | |
| US4575374A (en) | Flexible anterior chamber lens | |
| AU728981B2 (en) | Segmented scleral band for treatment of presbyopia and other eye disorders | |
| EP0403495B1 (en) | ''spare parts'' for ophthalmic surgical procedures | |
| US6881225B2 (en) | Intraocular lenses with a groove for closing the opening of the posterior capsule | |
| US6197056B1 (en) | Segmented scleral band for treatment of presbyopia and other eye disorders | |
| EP0342895B1 (en) | Ophthalmic lens | |
| US4485499A (en) | Intraocular posterior chamber lens | |
| US4648878A (en) | Posterior chamber lens implant | |
| US5098438A (en) | Procedures for intraocular surgery | |
| US4547914A (en) | Intraocular posterior chamber lens | |
| US4242762A (en) | Posterior encapsuled implant lens | |
| KR890701071A (ko) | 안내보철 | |
| US4585455A (en) | Intraocular lens with iris spacer mechanism | |
| US4725276A (en) | Intraocular lens with continuous posterior ring-like member | |
| US4547915A (en) | Intraocular posterior chamber lens | |
| WO1985004566A1 (en) | Posterior chamber intraocular lens | |
| US4661109A (en) | Intraocular lens | |
| USRE31626E (en) | Intraocular lens |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
| 17P | Request for examination filed |
Effective date: 19851221 |
|
| AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): DE FR GB SE |
|
| A4 | Supplementary search report drawn up and despatched |
Effective date: 19870706 |
|
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
| RIN1 | Information on inventor provided before grant (corrected) |
Inventor name: VERZELLA, FRANCOCENTRO DI MICROCHIRURGIA OFT. |